Michael
Analyst
Maxim Group
Equibles does not estimate personal net worth.
About Michael
Michael is recorded as Analyst at Maxim Group. Michael has spoken on 1 earnings call across 1 company, most recently for Capricor Therapeutics, Inc. on May 12, 2026. The companies whose calls Michael spoke on are classified in the Healthcare sector.
Michael on recent calls
“And I mean, lots of interesting stuff going on here. I would like to see if you could just provide a bit more color on what the basis for a suspension or an injunction of the commercial agreement would be.”
Affiliation history
-
Maxim Group
Analyst
Transcript header (unverified)
Current